• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    238.60 0.00(0.00%) Jun 22, 4:00PM EDT
    Add to Portfolio
    Company EventsGet Company Events for:
    Upcoming Events 
    DateEvent
    Jul 28 - Aug 3, 2015 (Est.)Earnings announcement
    Recent Events 
    DateEvent
    23-Jun-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting o
    7-May-15Synageva Biopharma downgraded by Robert W. Baird and Wedbush
    6-May-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc
    30-Apr-15SYNAGEVA BIOPHARMA CORP Files SEC form 10-Q, Quarterly Report
    29-Apr-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    26-Feb-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    9-Feb-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
    2-Feb-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
    7-Jan-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
    30-Oct-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    22-Sep-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
    9-Sep-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers
    31-Jul-14SYNAGEVA BIOPHARMA CORP Files SEC form 10-Q, Quarterly Report
    30-Jul-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    30-Jun-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
    9-Jun-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vot